Curated GI articles July 23rd, 2021:
8 recent GI expansions
What will PE do to GI care? 4 physicians weigh in (Becker’s GI & Endoscopy)
Four gastroenterologists told Becker’s ASC Review how they predict private equity will affect the GI landscape and patient care.
New Insurance Policy Irks Some GIs (Gastroenterology & Endoscopy News)
Patients insured by Empire BlueCross BlueShield will now need preapproval to receive care in a hospital outpatient setting if another facility, such as a freestanding ASC, could be used instead.
AGA publishes clinical practice update on chemoprevention of colorectal neoplasia (Healio)
The American Gastroenterological Association published a clinical practice update to describe the role of medications for the chemoprevention of colorectal neoplasia.
8 recent GI expansions (Becker’s GI & Endoscopy)
GI Alliance expanded to Utah, Colorado and Illinois in the past month. Here are eight recent expansions from gastroenterology practices and groups.
No Surprises Act Passes, Targeting Unexpected Bills (Gastroenterology & Endoscopy News)
The No Surprises Act goes into effect on Jan. 1, 2022. It prohibits out-of-network providers or facilities from balance billing patients in both emergency and nonemergency settings.
More Patients Willing To Switch To Doctors With Better Digital Tools (PYMNTS.com)
Gen Z, millennial and bridge millennial patients willing to change to physicians offering better digital healthcare management tools went from 31 percent in 2020 to 35 percent in 2021.
3 hospitals, health systems taking advantage of AI in gastroenterology (Becker’s GI & Endoscopy)
Becker’s ASC Review reports on three hospitals and health systems exploring artificial intelligence in gastroenterology and endoscopy care so far this year
‘It’s an obvious step backwards’: ASC execs pan CMS’ 2022 proposed pay changes (Becker’s ASC Review)
ASC owners and executives are critical of CMS’ plan to cut procedures from the ASC payable list and add several surgeries back to the inpatient-only list after removing them in January.
Clinical Characteristics and Treatment Response in Microscopic Colitis Based on Age at Diagnosis (Physician’s Weekly)
There are no significant differences in Microscopic Colitis (MC) treatment response based on age or disease subtype. These findings support treating patients with MC based on symptom severity rather than age.
You’re Missing Microbes. But Is ‘Rewilding’ the Way to Get Them Back? (The New York Times)
The science behind the idea of restoring the intestinal microbiome to an ancestral state is shaky, skeptics say, and in some cases unethical.
Building a Better FIT Test for Colon Cancer Screening (Medscape)
An antibody-based multitarget fecal immunochemical test (mtFIT) is more accurate in detecting advanced neoplasia compared with the standard FIT test, without compromising specificity, report Dutch researchers.
Study: Exposure Therapy for Irritable Bowel Syndrome Saves Money (MedPage Today)
At 6 months after treatment, a return-on-investment analysis showed a return of $5.64 for every $1 invested in ICBT with exposure therapy, according to the findings in BMC Gastroenterology.
Microbiome-focused Vedanta expands new fundraise to launch 2 studies (Endpoints News)
The company wrapped up a $68 million Series D raise Wednesday morning, which included the $25 million equity investment Pfizer plunked down back in January.
Fiber Dose Boosts FMT Effects in Clinical Trial (Gastroenterology & Endoscopy News)
Fiber supplementation appeared to modulate the response to fecal microbiota transplantation in patients with severe obesity and metabolic syndrome, researchers have found.
Q&A: Multitarget FIT bests regular FIT in adenoma detection (Healio)
Multitarget FIT yielded better diagnostic accuracy in the detection of advanced adenomas compared with basic FIT, according to research published in Annals of Internal Medicine.
Physicians Turning to Side Gigs for Extra Pay (Medscape)
To gauge the prevalence of side gigs among physicians, Medscape surveyed more than 2500 practicing doctors in the United States about their side gigs ― what they do, what they earn, and what they hope to gain.
GIs should wear ‘internal medicine hats’ to care for IBD across all ages (Healio)
The range of IBD across the ages highlights the importance of wearing our internal medicine hats when caring for these patients.
FDA OKs Odevixibat for Pruritus Associated With Rare Liver Disease (Medscape)
The FDA has approved odevixibat (Bylvay, Albireo Pharma), the first treatment for pruritus associated with all types of progressive familial intrahepatic cholestasis (PFIC).
Effect of a deep learning-based system on the miss rate of gastric neoplasms during upper GI endoscopy (The Lancet)
The use of an AI system during upper gastrointestinal endoscopy significantly reduced the gastric neoplasm miss rate. AI-assisted endoscopy has the potential to improve the yield of gastric neoplasms by endoscopists.
Mary Thomson, MD: The Future of NASH Care (HCPLive)
Thomson, a lead author on TARGET-NASH, recently told HCPLive® that statin use is underutilized in this patient population, largely due to the risks associated with the treatment for additional liver damage.
Low-FODMAP, gluten-free diet improves IBS symptoms (Healio)
Patients with IBS had improved symptom severity and normalized gut microbiota while following a low-FODMAP diet combined with a gluten-free diet.
Metabolic Syndrome Linked to Internal Hemorrhoids in Older Patients (Gastroenterology & Endoscopy News)
Older people with metabolic syndrome appear to be at a significantly greater risk for developing internal hemorrhoids and diverticular complaints, researchers have found.
More Hot headlines in GI
WHO Report Targets AI in Health, Cautions Against Health Disparities (HealthITAnalytics)